Denali Therapeutics Inc to Discuss the FDA Approval of AVLAYAH Conference Call Transcript
Thank you for standing by and welcome to the Ablaa FDA approval call. At this time, all participants are in listen-only mode. After the speaker's presentation, there will be a question-and-answer session.
To ask a question during this session, you'll need to press 11 on your telephone. If your question has been answered and you'd like to remove yourself from the queue, simply press 11 again. As a reminder, today's program is being recorded.
And now I'd like to introduce your host for today's program, Laura Henson, Vice President of investor relations. Please go ahead.
Thank you, Jonathan, and good day everyone.
Thank you for joining us today for our Aza FDA approval conference call. I'm Laura Hanson, Vice President of Investor relations at Tonelli Therapeutics. Joining me on the call today are Ryan Watts, Chief Executive Officer, Alexander Shu, Chief Financial and operating Officer. Peter Chin, Chief Medical Officer, and Katie Pang, Chief Commercial Officer
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
